CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Mainly Beta (13760)
(-)
Architecture: Ribbon (789)
(-)
Topology: Laminin (270)
(-)
Homologous Superfamily: Laminin (263)
(-)
Bos taurus. Organism_taxid: 9913 (1)
1CCFA:45-86HOW AN EPIDERMAL GROWTH FACTOR (EGF)-LIKE DOMAIN BINDS CALCIUM-HIGH RESOLUTION NMR STRUCTURE OF THE CALCIUM FORM OF THE NH2-TERMINAL EGF-LIKE DOMAIN IN COAGULATION FACTOR X
(-)
Cattle (Bos taurus) (4)
1APOA:45-86THREE-DIMENSIONAL STRUCTURE OF THE APO FORM OF THE N-TERMINAL EGF-LIKE MODULE OF BLOOD COAGULATION FACTOR X AS DETERMINED BY NMR SPECTROSCOPY AND SIMULATED FOLDING
1KIGL:389-439BOVINE FACTOR XA
1WHEA:47-86COAGULATION FACTOR, NMR, 20 STRUCTURES
1WHFA:47-86COAGULATION FACTOR, NMR, 15 STRUCTURES
(-)
Corynebacterium diphtheriae. Organism_taxid: 1717. Variant: lysogenized by the corynephage beta. (1)
1XDTR:107-147COMPLEX OF DIPHTHERIA TOXIN AND HEPARIN-BINDING EPIDERMAL GROWTH FACTOR
(-)
Dog hookworm (Ancylostoma caninum) (1)
1COUA:1-85ANTICOAGULANT PROTEIN FROM THE NEMATODE ANCYLOSTOMA CANINUM
(-)
Domestic sheep,lambs,wild sheep (Ovis aries) (1)
3KK6A:33-73; B:33-73CRYSTAL STRUCTURE OF CYCLOOXYGENASE-1 IN COMPLEX WITH CELECOXIB
(-)
Fire-bellied toad (Bombina bombina) (1)
1HX2A:1-60SOLUTION STRUCTURE OF BSTI, A TRYPSIN INHIBITOR FROM BOMBINA BOMBINA.
(-)
Fruit fly (Drosophila melanogaster) (2)
3C9AC:50-97; D:50-97HIGH RESOLUTION CRYSTAL STRUCTURE OF ARGOS BOUND TO THE EGF DOMAIN OF SPITZ
3CA7A:48-97HIGH RESOLUTION CRYSTAL STRUCTURE OF THE EGF DOMAIN OF SPITZ
(-)
Homo sapiens. Organism_taxid: 9606. Homo sapiens. Organism_taxid: 9606. (1)
3F6UL:94-146; L:49-93CRYSTAL STRUCTURE OF HUMAN ACTIVATED PROTEIN C (APC) COMPLEXED WITH PPACK
(-)
Honey bee (Apis mellifera) (1)
1CCVA:1-56NMR SOLUTION STRUCTURE OF APIS MELLIFERA CHYMOTRYPSIN INHIBITOR (AMCI).
(-)
House mouse (Mus musculus) (18)
1A3PA:4-48ROLE OF THE 6-20 DISULFIDE BRIDGE IN THE STRUCTURE AND ACTIVITY OF EPIDERMAL GROWTH FACTOR, NMR, 20 STRUCTURES
1CVUA:33-73; B:2033-2073CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2
1CX2A:33-73; B:33-73; C:33-73; D:33-73CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A SELECTIVE INHIBITOR, SC-558
1DDXA:33-73; B:1033-1073; C:2033-2073; D:3033-3073CRYSTAL STRUCTURE OF A MIXTURE OF ARACHIDONIC ACID AND PROSTAGLANDIN BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2: PROSTAGLANDIN STRUCTURE
1EGFA:1-53SOLUTION STRUCTURE OF MURINE EPIDERMAL GROWTH FACTOR DETERMINED BY NMR SPECTROSCOPY AND REFINED BY ENERGY MINIMIZATION WITH RESTRAINTS
1EPGA:1-53THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1EPHA:1-53THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1EPIA:1-53THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1EPJA:1-53THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1KLOA:11-63; A:120-172; A:64-119CRYSTAL STRUCTURE OF THREE CONSECUTIVE LAMININ-TYPE EPIDERMAL GROWTH FACTOR-LIKE (LE) MODULES OF LAMININ GAMMA1 CHAIN HARBORING THE NIDOGEN BINDING SITE
1NPEB:738-790; B:847-899; B:791-846CRYSTAL STRUCTURE OF NIDOGEN/LAMININ COMPLEX
1PXXA:35-73; C:2033-2073; D:3033-3073; B:1033-1073CRYSTAL STRUCTURE OF DICLOFENAC BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2
1TLEA:1-58LE (LAMININ-TYPE EGF-LIKE) MODULE GIII4 IN SOLUTION AT PH 3.5 AND 290 K, NMR, 14 STRUCTURES
3EGFA:1-53SOLUTION STRUCTURE OF MURINE EPIDERMAL GROWTH FACTOR DETERMINED BY NMR SPECTROSCOPY AND REFINED BY ENERGY MINIMIZATION WITH RESTRAINTS
3PGHA:33-73; B:33-73; C:33-73; D:33-73CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A NON-SELECTIVE INHIBITOR, FLURBIPROFEN
4COXA:33-73; B:33-73; C:33-73; D:33-73CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A NON-SELECTIVE INHIBITOR, INDOMETHACIN
5COXA:33-73; B:33-73; C:33-73; D:33-73UNINHIBITED MOUSE CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2)
6COXA:33-73; B:33-73CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A SELECTIVE INHIBITOR, SC-558 IN I222 SPACE GROUP
(-)
Human (Homo sapiens) (195)
1ADXA:1-40FIFTH EGF-LIKE DOMAIN OF THROMBOMODULIN (TMEGF5), NMR, 14 STRUCTURES
1APQA:23-75STRUCTURE OF THE EGF-LIKE MODULE OF HUMAN C1R, NMR, 19 STRUCTURES
1AUTL:94-145; L:49-93HUMAN ACTIVATED PROTEIN C
1BF9A:45-85N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES
1C5MF:0-51STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1CVWL:90-144CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR VIIA (DES-GLA)
1DQBA:1-46; A:47-83NMR STRUCTURE OF THROMBOMODULIN EGF(4-5)
1DVAL:49-85; M:49-85; L:86-142; M:86-142CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA
1DX5I:345-389; J:345-389; K:345-389; L:345-389; I:423-462; J:423-462; K:423-462; L:423-462; I:390-422; J:390-422; K:390-422; L:390-422CRYSTAL STRUCTURE OF THE THROMBIN-THROMBOMODULIN COMPLEX
1EZQB:0-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515
1F0RB:0-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815
1F0SB:0-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707
1F7EA:45-90THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, 20 STRUCTURES
1F7MA:45-90THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, MINIMIZED AVERAGE STRUCTURE
1FAKL:87-143; L:36-86HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT
1FAXL:85-139COAGULATION FACTOR XA INHIBITOR COMPLEX
1FF7A:45-90THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES
1FFMA:45-90THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE
1FJSL:87-138CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA
1FSBA:1-40STRUCTURE OF THE EGF DOMAIN OF P-SELECTIN, NMR, 19 STRUCTURES
1G1QA:120-157; B:120-157; C:120-157; D:120-157CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS
1G1RA:120-157; B:120-157; C:120-157; D:120-157CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX
1G1SA:120-157; B:120-157P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE
1G1TA:120-157CRYSTAL STRUCTURE OF E-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX
1G2LB:251-305FACTOR XA INHIBITOR COMPLEX
1G2MB:385-439FACTOR XA INHIBITOR COMPLEX
1HAEA:1-63HEREGULIN-ALPHA EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, NMR, 20 STRUCTURES
1HAFA:1-63HEREGULIN-ALPHA EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE
1HCGB:1-51STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 ANGSTROMS RESOLUTION
1HJ7A:334-372; A:293-333NMR STUDY OF A PAIR OF LDL RECEPTOR CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, 20 STRUCTURES
1HREA:175-241SOLUTION STRUCTURE OF THE EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HEREGULIN-ALPHA, A LIGAND FOR P180ERB4
1HRFA:175-241SOLUTION STRUCTURE OF THE EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HEREGULIN-ALPHA, A LIGAND FOR P180ERB4
1HZ8A:42-80; A:1-41SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR
1I0UA:42-82; A:1-41SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR
1IJQA:639-692; B:639-692CRYSTAL STRUCTURE OF THE LDL RECEPTOR YWTD-EGF DOMAIN PAIR
1IOEL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55532
1IOXA:1-50NMR STRUCTURE OF HUMAN BETACELLULIN-2
1IP0A:1-50NMR STRUCTURE OF HUMAN BETACELLULIN-2
1IQEL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55590
1IQFL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55165
1IQGL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55159
1IQHL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55143
1IQIL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55125
1IQJL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55124
1IQKL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55113
1IQLL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54476
1IQML:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54471
1IQNL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55192
1IVOC:5-51; D:5-51CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN EPIDERMAL GROWTH FACTOR AND RECEPTOR EXTRACELLULAR DOMAINS.
1J9CL:89-142; L:48-88CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX
1JBUL:90-143COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEX WITH INHIBITORY EXOSITE PEPTIDE A-183
1JL9B:6-50; A:6-47CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR
1K36A:1-46NMR STRUCTURE OF HUMAN EPIREGULIN
1K37A:1-46NMR STRUCTURE OF HUMAN EPIREGULIN
1KLIL:84-144COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA
1KLJL:89-144CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA
1KSNB:-1-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH FXV673
1KYE  [entry was replaced by entry 3LIW without any CATH domain information]
1L3YA:1-41INTEGRIN EGF-LIKE MODULE 3 FROM THE BETA-2 SUBUNIT
1LMJA:3-88NMR STUDY OF THE FIBRILLIN-1 CBEGF12-13 PAIR OF CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS
1LPGA:1A-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.
1LPKA:1A-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.
1LPZA:1A-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.
1LQDA:1A-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.
1MOXD:3-50; C:2-50CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA
1MQ5L:87-137CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL) AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA
1MQ6L:87-137CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2-PYRIDINYL) AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-OXAZOLYL) METHYLAMINO]METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA
1N7DA:333-377; A:295-332; A:643-693EXTRACELLULAR DOMAIN OF THE LDL RECEPTOR
1NFUB:-2-49CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747
1NFWB:0-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685
1NFXB:-2-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944
1NFYB:-2-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095
1NQLB:3-50STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN EPIDERMAL GROWTH FACTOR (EGF) RECEPTOR IN AN INACTIVE (LOW PH) COMPLEX WITH EGF.
1NZIB:118-159; A:118-159CRYSTAL STRUCTURE OF THE CUB1-EGF INTERACTION DOMAIN OF COMPLEMENT PROTEASE C1S
1O5DL:89-142; L:47-88DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
1P0SL:48-129CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEX WITH ECOTIN M84R
1P9JA:1-54SOLUTION STRUCTURE AND DYNAMICS OF THE EGF/TGF-ALPHA CHIMERA T1E
1QFKL:86-144; L:49-85STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION
1RFNB:86-142HUMAN COAGULATION FACTOR IXA IN COMPLEX WITH P-AMINO BENZAMIDINE
1SZBA:126-168; B:126-168CRYSTAL STRUCTURE OF THE HUMAN MBL-ASSOCIATED PROTEIN 19 (MAP19)
1TOZA:411-453NMR STRUCTURE OF THE HUMAN NOTCH-1 LIGAND BINDING REGION
1TPGA:47-91F1-G MODULE PAIR RESIDUES 1-91 (C83S) OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) (NMR, 298K, PH2.95, REPRESENTATIVE STRUCTURE)
1U8CB:1563-1604; B:1523-1562A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE
1URKA:6-49SOLUTION STRUCTURE OF THE AMINO TERMINAL FRAGMENT OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
1UZJA:1486-1530; B:2486-2530; C:3486-3530INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, HOLO FORM.
1UZKA:1486-1530INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, CA BOUND TO CBEGF23 DOMAIN ONLY
1UZPA:1486-1530INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, SM BOUND FORM CBEGF23 DOMAIN ONLY.
1UZQA:1486-1530INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, APO FORM CBEGF23 DOMAIN ONLY.
1V3XB:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE
1W7XL:90-144FACTOR7 - 413 COMPLEX
1W8BL:88-143FACTOR7 - 413 COMPLEX
1WU1B:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5-CHLOROINDOL-2-YL) SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE
1XFEA:39-83SOLUTION STRUCTURE OF THE LA7-EGFA PAIR FROM THE LDL RECEPTOR
1XKAL:86-135; L:49-85FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
1XKBA:87-135; B:87-135; A:48-86; B:50-86FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
1YGCL:90-142SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR
1YUFA:1-50TYPE ALPHA TRANSFORMING GROWTH FACTOR, NMR, 16 MODELS WITHOUT ENERGY MINIMIZATION
1YUGA:1-50TYPE ALPHA TRANSFORMING GROWTH FACTOR, NMR, 15 MODELS AFTER ECEPP/3 ENERGY MINIMIZATION
1Z6EL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3'-AMINO-1,2-BENZISOXAZOL-5'-YL)-N-(4-(2'-((DIMETHYLAMINO)METHYL)-1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE (RAZAXABAN; DPC906; BMS-561389)
1ZAQA:1-44FOURTH EGF-LIKE DOMAIN OF THROMBOMODULIN, NMR, 12 STRUCTURES
2ADXA:1-40FIFTH EGF-LIKE DOMAIN OF THROMBOMODULIN (TMEGF5), NMR, MINIMIZED AVERAGE STRUCTURE
2B7DL:89-142; L:49-88FACTOR VIIA INHIBITORS: CHEMICAL OPTIMIZATION, PRECLINICAL PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY IN A BABOON THROMBOSIS MODEL
2BMGA:-3-50CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50
2BOHA:-3-51CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND "1"
2BOKL:87-138FACTOR XA - CATION
2BQ6A:1A-49CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21
2BQ7A:-2-49CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43
2BQWA:-2-49CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45
2BZ6L:90-142ORALLY AVAILABLE FACTOR7A INHIBITOR
2CJIB:-1-50CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2D1JB:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 2-[[4-[(5-CHLOROINDOL-2-YL)SULFONYL]PIPERAZIN-1-YL] CARBONYL]THIENO[3,2-B]PYRIDINE N-OXIDE
2EI6B:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-CIS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE
2EI7B:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR TRANS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE
2EI8B:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-4-(N,N-DIMETHYLCARBAMOYL)-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL) CARBONYL]-1,2-CYCLOHEXANEDIAMINE
2F9BL:89-142; L:49-88DISCOVERY OF NOVEL HETEROCYCLIC FACTOR VIIA INHIBITORS
2FD6A:11-49STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
2FLBL:89-142; L:47-88DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR
2FLRL:89-142; L:47-88NOVEL 5-AZAINDOLE FACTOR VIIA INHIBITORS
2FZZL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE
2G00L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1-YL)BENZAMIDE
2GD4A:87-138; L:86-139CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
2H9EL:89-136CRYSTAL STRUCTURE OF FXA/SELECTIDE/NAPC2 TERNARY COMPLEX
2I9AB:6-49; A:10-49; D:10-49; C:11-49CRYSTAL STRUCTURE OF THE FREE AMINOTERMINAL FRAGMENT OF UROKINASE TYPE PLASMINOGEN ACTIVATOR (ATF)
2I9BA:11-49; B:11-49; C:11-49; D:11-49CRYSTAL STRUCTURE OF ATF-UROKINASE RECEPTOR COMPLEX
2J2UB:-2-49CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J34B:-1-50CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J38B:-1-49CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J4IB:-2-49CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J94B:-2-49CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J95B:-1-50CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2JKHL:87-140FACTOR XA - CATION INHIBITOR COMPLEX
2P16L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE
2P3FL:88-138CRYSTAL STRUCTURE OF THE FACTOR XA/NAP5 COMPLEX
2P3TA:87-138CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-4-(2-METHYLAMINO-IMIDAZOL-1-YLMETHYL)-THIOPHENE-2-CARBOXYLIC ACID [4-CHLORO-2-(5-CHLORO-PYRIDIN-2-YLCARBAMOYL)-6-METHOXY-PHENYL]-AMIDE
2P3UA:87-137CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-N-(4-CHLORO-2-{[(5-CHLOROPYRIDIN-2-YL) AMINO]CARBONYL}-6-METHOXYPHENYL)-4-[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]THIOPHENE-2-CARBOXAMIDE {PFIZER 320663}
2P93L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE
2P94L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)CYCLOHEXYL)-1H-INDOLE-6-CARBOXAMIDE
2P95L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL) THIOPHENE-2-CARBOXAMIDE
2PHBB:0-50AN ORALLY EFFICACIOUS FACTOR XA INHIBITOR
2PR3B:1-50FACTOR XA INHIBITOR
2PUQL:89-142; L:49-88CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA IN COMPLEX WITH SOLUBLE TISSUE FACTOR
2Q1JB:0-50THE DISCOVERY OF GLYCINE AND RELATED AMINO ACID-BASED FACTOR XA INHIBITORS
2RA0L:88-138X-RAY STRUCTURE OF FXA IN COMPLEX WITH 7-FLUOROINDAZOLE
2TGFA:1-50THE SOLUTION STRUCTURE OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA
2UWLB:-2-49SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA
2UWOB:-2-49SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA
2UWPB:-2-49FACTOR XA INHIBITOR COMPLEX
2VH0B:-2-49STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS
2VH6B:-3-50STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS
2VVCL:87-138; K:86-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VVUL:86-140AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VVVL:87-140AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR
2VWLL:89-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VWML:86-137; K:86-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VWNL:88-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VWOL:88-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2W26B:0A-49FACTOR XA IN COMPLEX WITH BAY59-7939
2W3IB:0-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2
2W3KB:0-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1
2W86A:1-45; A:106-147CRYSTAL STRUCTURE OF FIBRILLIN-1 DOMAINS CBEGF9HYB2CBEGF10, CALCIUM SATURATED FORM
2WPHE:87-145FACTOR IXA SUPERACTIVE TRIPLE MUTANT
2WPIE:87-145FACTOR IXA SUPERACTIVE DOUBLE MUTANT
2WPJE:87-145FACTOR IXA SUPERACTIVE TRIPLE MUTANT, NACL-SOAKED
2WPKE:87-145FACTOR IXA SUPERACTIVE TRIPLE MUTANT, ETHYLENE GLYCOL-SOAKED
2WPLE:87-145FACTOR IXA SUPERACTIVE TRIPLE MUTANT, EDTA-SOAKED
2WPME:87-145FACTOR IXA SUPERACTIVE MUTANT, EGR-CMK INHIBITED
2XBVL:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XBWL:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XBXL:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XBYL:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XC0L:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XC4L:87-140FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XC5L:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
3BT1A:8-49STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX
3BT2A:9-49STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX
3CENL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR N-(2-(((5-CHLORO-2-PYRIDINYL) AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
3CFWA:120-156L-SELECTIN LECTIN AND EGF DOMAINS
3CS7L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-METHOXYPHENYL)-6-(4-(1-(PYRROLIDIN-1-YLMETHYL)CYCLOPROPYL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3DEMA:121-164; B:121-164CUB1-EGF-CUB2 DOMAIN OF HUMAN MASP-1/3
3ELAL:89-142; L:48-88CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA MUTANT IN COMPLEX WITH SOLUBLE TISSUE FACTOR
3ENSA:126-175; C:126-175; A:90-125; C:89-125CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH METHYL (2Z)-3-[(3-CHLORO-1H-INDOL-7-YL)AMINO]-2-CYANO-3-{[(3S)-2-OXO-1-(2-OXO-2-PYRROLIDIN-1-YLETHYL)AZEPAN-3-YL]AMINO}ACRYLATE
3F1SB:87-137CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR
3FFGL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR (R)-6-(2'-((3-HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4, 5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3GISY:348-389; X:349-389; Z:350-389; X:423-463; Y:423-463; Z:423-463; Z:390-422; X:390-422; Y:390-422CRYSTAL STRUCTURE OF NA-FREE THROMBIN IN COMPLEX WITH THROMBOMODULIN
3HPTA:126-175; C:126-175; C:89-125; A:90-125CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH (S)-2-CYANO-1-(2-METHYLBENZOFURAN-5-YL)-3-(2-OXO-1-(2-OXO-2-(PYRROLIDIN-1-YL)ETHYL) AZEPAN-3-YL)GUANIDINE
3KCGL:84-137CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA-PENTASACCHARIDE COMPLEX
3KL6B:-1-48DISCOVERY OF TETRAHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVE TAK-442: A POTENT, SELECTIVE AND ORALLY ACTIVE FACTOR XA INHIBITOR
3KQBL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR N-(3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H- 1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-1H- PYRAZOLE-5-CARBOXAMIDE
3KQCL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 6-(2'- (METHYLSULFONYL) BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H- 1,2,4-TRIAZOL-3-YL) PHENYL)-3-(TRIFLUOROMETHYL)-5,6- DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3KQDL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-(5-OXO-4,5- DIHYDRO-1H-1, 2,4-TRIAZOL-3-YL)PHENYL)-6-(2'-(PYRROLIDIN-1- YLMETHYL)BIPHENYL-4-YL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO- 1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3KQEL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-METHYL-1-(3-(5- OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-6-(2'- (PYRROLIDIN-1-YLMETHYL) BIPHENYL-4-YL)-5,6-DIHYDRO-1H- PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3LC3B:86-142; D:86-142BENZOTHIOPHENE INHIBITORS OF FACTOR IXA
3LC5B:86-139SELECTIVE BENZOTHIOPHINE INHIBITORS OF FACTOR IXA
3TGFA:1-50THE SOLUTION STRUCTURE OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA
4TGFA:1-50SOLUTION STRUCTURES OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA DERIVED FROM 1*H NMR DATA
(-)
Malaria parasite p (Plasmodium falciparum) (1)
1CEJA:1-44; A:45-96SOLUTION STRUCTURE OF AN EGF MODULE PAIR FROM THE PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEIN 1
(-)
Mouse (Mus musculus) (6)
1OB1C:1-44; F:1-44; C:45-96; F:45-97CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
3HS5A:33-73; B:33-73X-RAY CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE CHANNEL OF CYCLOOXYGENASE-2
3HS6A:33-73; B:33-73X-RAY CRYSTAL STRUCTURE OF EICOSAPENTAENOIC ACID BOUND TO THE CYCLOOXYGENASE CHANNEL OF CYCLOOXYGENASE-2
3HS7A:33-73; B:33-73X-RAY CRYSTAL STRUCTURE OF DOCOSAHEXAENOIC ACID BOUND TO THE CYCLOOXYGENASE CHANNEL OF CYCLOOXYGENASE-2
3KRKA:33-73; B:33-73X-RAY CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF L531F MURINE COX-2
3LAQB:8-50; A:9-50STRUCTURE-BASED ENGINEERING OF SPECIES SELECTIVITY IN THE UPA-UPAR INTERACTION
(-)
Mus musculus. Organism_taxid: 10090 (1)
1GK5A:1-49SOLUTION STRUCTURE THE MEGF/TGFALPHA44-50 CHIMERIC GROWTH FACTOR
(-)
Norway rat (Rattus norvegicus) (1)
1NT0A:120-163; G:120-163CRYSTAL STRUCTURE OF THE CUB1-EGF-CUB2 REGION OF MASP2
(-)
Pig (Sus scrofa) (3)
1EAIC:1-61; D:1-61COMPLEX OF ASCARIS CHYMOTRPSIN/ELASTASE INHIBITOR WITH PORCINE ELASTASE
1PFXL:87-127; L:47-86PORCINE FACTOR IXA
1X7AL:86-127; L:50-85PORCINE FACTOR IXA COMPLEXED TO 1-{3-[AMINO(IMINO) METHYL]PHENYL}-N-[4-(1H-BENZIMIDAZOL-1-YL)-2-FLUOROPHENYL]-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE
(-)
Pig roundworm (Ascaris suum) (4)
1ATAA:1-62HIGH-RESOLUTION STRUCTURE OF ASCARIS TRYPSIN INHIBITOR IN SOLUTION: DIRECT EVIDENCE FOR A PH INDUCED CONFORMATIONAL TRANSITION IN THE REACTIVE SITE
1ATBA:1-62HIGH-RESOLUTION STRUCTURE OF ASCARIS TRYPSIN INHIBITOR IN SOLUTION: DIRECT EVIDENCE FOR A PH INDUCED CONFORMATIONAL TRANSITION IN THE REACTIVE SITE
1ATDA:1-62HIGH-RESOLUTION STRUCTURE OF ASCARIS TRYPSIN INHIBITOR IN SOLUTION: DIRECT EVIDENCE FOR A PH INDUCED CONFORMATIONAL TRANSITION IN THE REACTIVE SITE
1ATEA:1-62HIGH-RESOLUTION STRUCTURE OF ASCARIS TRYPSIN INHIBITOR IN SOLUTION: DIRECT EVIDENCE FOR A PH INDUCED CONFORMATIONAL TRANSITION IN THE REACTIVE SITE
(-)
Plasmodium cynomolgi. Organism_taxid: 5827. (1)
1B9WA:1-51; A:52-89C-TERMINAL MEROZOITE SURFACE PROTEIN 1 FROM PLASMODIUM CYNOMOLGI
(-)
Plasmodium knowlesi strain h. Organism_taxid: 5851. Strain: malayan h. (1)
1N1IA:8-54; B:8-54; D:8-54; C:9-54; C:55-101; B:55-100; A:55-98; D:55-94THE STRUCTURE OF MSP-1(19) FROM PLASMODIUM KNOWLESI
(-)
Plasmodium vivax (strain belem). Organism_taxid: 31273. Strain: belem. (1)
2NPRA:1-52; A:53-90STRUCTURAL STUDIES ON PLASMODIUM VIVAX MEROZOITE SURFACE PROTEIN-1
(-)
Sheep (Ovis aries) (18)
1CQEA:33-73; B:33-73PROSTAGLANDIN H2 SYNTHASE-1 COMPLEX WITH FLURBIPROFEN
1DIYA:33-73CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND IN THE CYCLOOXYGENASE ACTIVE SITE OF PGHS-1
1EBVA:33-73OVINE PGHS-1 COMPLEXED WITH SALICYL HYDROXAMIC ACID
1EQGA:33-73; B:33-73THE 2.6 ANGSTROM MODEL OF OVINE COX-1 COMPLEXED WITH IBUPROFEN
1EQHA:33-73; B:33-73THE 2.7 ANGSTROM MODEL OF OVINE COX-1 COMPLEXED WITH FLURBIPROFEN
1FE2A:33-73CRYSTAL STRUCTURE OF DIHOMO-GAMMA-LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.
1HT5A:33-73; B:33-73THE 2.75 ANGSTROM RESOLUTION MODEL OF OVINE COX-1 COMPLEXED WITH METHYL ESTER FLURBIPROFEN
1HT8A:33-73; B:33-73THE 2.7 ANGSTROM RESOLUTION MODEL OF OVINE COX-1 COMPLEXED WITH ALCLOFENAC
1IGXA:33-73CRYSTAL STRUCTURE OF EICOSAPENTANOIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.
1IGZA:33-73CRYSTAL STRUCTURE OF LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.
1PGEA:33-73; B:33-73PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH P-(2'-IODO-5'-THENOYL) HYDROTROPIC ACID (IODOSUPROFEN)
1PRHA:33-73; B:33-73THE X-RAY CRYSTAL STRUCTURE OF THE MEMBRANE PROTEIN PROSTAGLANDIN H2 SYNTHASE-1
1PTHA:33-73; B:33-73THE STRUCTURAL BASIS OF ASPIRIN ACTIVITY INFERRED FROM THE CRYSTAL STRUCTURE OF INACTIVATED PROSTAGLANDIN H2 SYNTHASE
1Q4GA:33-73; B:33-732.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID
1U67A:33-73CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO A MUTANT OF PROSTAGLADIN H SYNTHASE-1 THAT FORMS PREDOMINANTLY 11-HPETE.
2AYLA:33-73; B:1033-10732.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX-RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN
2OYEP:33-73INDOMETHACIN-(R)-ALPHA-ETHYL-ETHANOLAMIDE BOUND TO CYCLOOXYGENASE-1
2OYUP:33-73INDOMETHACIN-(S)-ALPHA-ETHYL-ETHANOLAMIDE BOUND TO CYCLOOXYGENASE-1